These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11109047)

  • 1. Postmenopausal hormone replacement therapy and breast cancer.
    Jacobs HS
    Medscape Womens Health; 2000; 5(4):E2. PubMed ID: 11109047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma.
    Diamanti-Kandarakis E; Sykiotis GP; Papavassiliou AG
    Cancer; 2003 Jan; 97(1):12-20. PubMed ID: 12491500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement therapy and breast cancer].
    Dobashi K
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):871-6. PubMed ID: 10396312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study.
    Wellejus A; Olsen A; Tjonneland A; Thomsen BL; Overvad K; Loft S
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2137-42. PubMed ID: 16172222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ; Taylor R; Wilcken N; Fiorica J; Boyages J
    Breast J; 2005; 11(6):410-5. PubMed ID: 16297085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)].
    Martin-Du Pan RC; Luzuy F
    Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone replacement therapy: endometrial and breast effects.
    Yeh IT
    Adv Anat Pathol; 2007 Jan; 14(1):17-24. PubMed ID: 17198307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and breast cancer.
    Jacobs HS
    Endocr Relat Cancer; 2000 Mar; 7(1):53-61. PubMed ID: 10808196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O; Metsä-Heikkilä M
    Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
    J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estrogen replacement therapy and breast cancer].
    Bakken K; Alsaker E; Eggen AE; Lund E
    Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
    Alvarez-Vasquez RB; Axelrod D; Frenkel K; Newman MC; Sepkovic DW; Bradlow HL; Zumoff B
    Horm Metab Res; 2003 Jun; 35(6):358-61. PubMed ID: 12920658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.